Patient Testimonials

ENT Research at the California Sinus Centers

 


Otolaryngology, ENT & Sinus News Provided by the California Sinus Centers

Therapeutic Sialendoscopy for the Management of Radioiodine Sialadenitis [Original Article]

January 1, 2012, 12:00 pm by Archives of Otolaryngology Head & Neck Surgery

Objective  To describe our experience with therapeutic sialendoscopy for radioiodine (iodine 131 [131I]) sialadenitis. Design  Retrospective medical chart review. Setting  Academic tertiary referral center. Patients  The study included 11 patients who underwent therapeutic sialendoscopy for the treatment of 131I sialadenitis after failing medical management. Interventions  Therapeutic sialendoscopy with dilation and irrigation of the ductal system was performed in all patients. Main Outcome Measures  Patient-reported frequency and severity of symptoms. Results  Our series included 9 women and 2 men (mean age, 51 years; age range, 35-65 years). A total of 23 parotid glands and 5 submandibular glands were treated. Sialendoscopy was possible in all patients, except one in whom the Stensen duct could not be cannulated. Typical endoscopic findings included pale ductal mucosa, thick mucous plugs, ductal debris, and stenosis of the duct. Most patients (91%) reported improvement of symptoms after a single procedure. Complete resolution of symptoms, with sustained benefit, was reported by 6 patients (54%) at a mean follow-up of 18 months. Partial improvement of symptoms, with some persistent intermittent episodes of pain or swelling, was reported by 4 patients (36%). One patient reported no subjective symptomatic improvement after 2 procedures and subsequently underwent a parotidectomy. Conclusions  Sialendoscopy is useful for the improvement of symptoms due to radioiodine-induced sialadenitis in patients who are refractory to conservative medical therapy. Therapeutic sialendoscopy appears to provide effective and sustained symptom improvement in most patients in our experience.

Read the full article


More from Archives of Otolaryngology Head & Neck Surgery

Incidence of Pediatric Acute Mastoiditis: 1997-2006 [Original Article]
Archives of Otolaryngology Head & Neck Surgery: April 16, 2012, 12:00 pm
Objectives  To evaluate the incidence of acute mastoiditis in children in the United States over the years 1997 through 2006 and to explore possible explanations for the conflicting conclusions of recent studies

Radiotherapy in Parotid Acinic Cell Carcinoma: Does It Have an Impact on Survival? [Original Article]
Archives of Otolaryngology Head & Neck Surgery: April 16, 2012, 12:00 pm
Objective  Acinic (or acinar) cell carcinoma (ACC) represents approximately 10% of salivary gland malignant tumors and most commonly occurs in the parotid gland. It carries a propensity for locoregional and distant metastasis.

Koi frenzy [About the Cover]
Archives of Otolaryngology Head & Neck Surgery: April 1, 2012, 12:00 pm


About This Journal [About This Journal]
Archives of Otolaryngology Head & Neck Surgery: April 1, 2012, 12:00 pm


Complications of Adenotonsillectomy in Patients Younger Than 3 Years [Original Article]
Archives of Otolaryngology Head & Neck Surgery: April 1, 2012, 12:00 pm
Objective  To evaluate the complication rate for adenotonsillectomy in children younger than 3 years, without a diagnosis of severe obstructive sleep apnea, to assess the necessity for postoperative inpatient admission. Design  Retrospective medical

 

NOTICE: The CSC web site "Otolaryngology ENT Industry News" has data and links presented by way of the above mentioned RSS news feeds. We offer this industry news for your convenience and education. CSC does not review the information provided in this section. CSC does not assume any endorsement or present these third-party feeds and links as CSC belief or in conjunction with CSC whatsoever. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the California Sinus Centers. For more information, please see our disclaimer.